FOMAT Medical Research Announces Joint Venture with Reumalab
Oxnard, CA, November, 2017 – FOMAT Medical Research, a leading organization in clinical research, will embark on a joint venture with Reumalab in order to provide clinical research services in the South American region that is set to improve clinical research services in Latin America.
FOMAT Medical Research will provide clinical and regulatory management for the new joint project, while Reumalab will address the operative issues that arise. FOMAT Medical Research has been well-known in the clinical research industry for managing high quality research in Latin America. Reumalab, a well-established organization in rheumatology and clinical research, brings their experience in the area and high quality facilities to the joint venture.
About FOMAT Medical Research
FOMAT Medical Research is an international company focused on innovating healthcare for Hispanics throughout the Americas. In the US, we are a Hispanic focused Site Management Organization (SMO) and in Latin America. We are a SMO with local Contract Research Organization (CRO) capabilities pioneering innative clinical trials throughout both regions.
In Latin America we assist in Clinical Research as a SMO with local CRO capabilities; which means that we can play both rolls especially in Ecuador, Colombia and Peru. This added benefit allows us to have the fastest start-up times in the region. So we can get your study up and running quickly and efficiently.
In 1969 Javier Molina, MD pioneer in the implementation of new techniques for the diagnosis of rheumatic diseases. He creates rheumatology services in the “Hospital San Vicente de Paul” and the Social Security Institute.
In the same year, he founded the Specialized Clinical Laboratory in Rheumatology. As a support to process the samples of his patients and make more precise diagnoses. Since then, the laboratory has been standard-bearer in the performance of different rheumatological tests: antinuclear antibodies, rheumatoid factors, synovial fluid study, anticardiolipin antibodies, biochemical markers for osteoporosis, among others.
Subsequently, his private practice and the clinical laboratory are transformed into the Rheumalab Integral Rheumatology Center in which the best diagnostic practices are combined. Reumalab care for patients with different pathologies and for 1997 in conjunction with Dr. José Fernando Molina, specialized research in patients with rheumatologic and autoimmune diagnoses.
Reumalab As a complementary discipline create the Osteoporosis Unit. With it begins the study of patients with metabolic bone diseases for which it has a latest generation densitometer and the best interpretation of the different tests to establish the diagnosis of diseases such as osteoporosis.